US Edition# Catheter Precision Faces Financial Scrutiny NYSE American Section 610(b) Public Announcement Raises Concerns Over G...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
# Catheter Precision Faces Financial Scrutiny NYSE American Section 610(b) Public Announcement Raises Concerns Over G...
In a significant development for investors and stakeholders in the medical device industry, Catheter Precision, Inc. (ticker: VTAK), a Virginia-based company specializing in the design and manufacture of advanced products for the cardiac electrophysiology market, released a public announcement pursuant to NYSE American Section 610(b). This announcement, dated April 17, 2025, draws attention to substantial financial uncertainties that have emerge…
Catheter Precision Makes NYSE American Section 610(b) Public Announcement
April 17, 2025 16:48 ET | Source: Catheter Precision, Inc. Fort Mill, S.C., April 17, 2025 (GLOBE NEWSWIRE) — — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that, as previously disclosed in its Annual Report on Form […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
